08:56 AM EST, 02/18/2025 (MT Newswires) -- Windtree Therapeutics ( WINT ) said Tuesday that its board approved a 1-for-50 reverse stock split, to go into effect Thursday after the close of trading.

The reverse split is meant to increase the share price to bring the biotech company into compliance with Nasdaq's $1.00 minimum bid price listing requirement.

Shares of the company were down more than 23% in recent premarket activity.